TABLE 2.
Flavonoid | Quintile 1 | Quintile 2 | Quintile 3 | Quintile 4 | Quintile 5 | P for trend |
Flavonols | ||||||
NHS II | ||||||
No. of cases | 2282 | 2214 | 2253 | 2313 | 2340 | — |
Person-years | 160,275 | 167,691 | 168,830 | 166,985 | 159,058 | — |
Relative risk (95% CI) | 1.0 (ref) | 0.97 (0.91, 1.03) | 0.97 (0.92, 1.04) | 0.98 (0.92, 1.05) | 1.00 (0.94, 1.07) | 0.58 |
NHS I | ||||||
No. of cases | 3560 | 3714 | 3623 | 3514 | 3205 | — |
Person-years | 103,645 | 105,671 | 103,580 | 101,502 | 96,684 | — |
Relative risk (95% CI) | 1.0 (ref) | 1.02 (0.97, 1.07) | 1.01 (0.96, 1.06) | 1.00 (0.95, 1.05) | 0.96 (0.91, 1.01) | 0.02 |
HPFS | ||||||
No. of cases | 1087 | 1170 | 1134 | 1141 | 1104 | — |
Person-years | 42,553 | 44,709 | 43,682 | 42,792 | 39,026 | — |
Relative risk (95% CI) | 1.0 (ref) | 1.02 (0.94, 1.12) | 1.01 (0.93, 1.11) | 1.01 (0.92, 1.11) | 1.07 (0.97, 1.18) | 0.17 |
Pooled relative risk (95% CI) | 1.0 (ref) | 1.00 (0.97, 1.04) | 1.00 (0.96, 1.03) | 1.00 (0.96, 1.03) | 1.00 (0.95, 1.01) | 0.99 |
Flavones | ||||||
NHS II | ||||||
No. of cases | 2360 | 2396 | 2228 | 2301 | 2117 | — |
Person-years | 155,081 | 165,536 | 166,431 | 169,171 | 166,619 | — |
Relative risk (95% CI) | 1.0 (ref) | 0.98 (0.93, 1.04) | 0.93 (0.87, 0.98) | 0.97 (0.91, 1.04) | 0.95 (0.88, 1.01) | 0.17 |
NHS I | ||||||
No. of cases | 3625 | 3830 | 3606 | 3394 | 3161 | — |
Person-years | 104,945 | 108,204 | 103,930 | 100,494 | 93,509 | — |
Relative risk (95% CI) | 1.0 (ref) | 1.00 (0.96, 1.05) | 0.98 (0.93, 1.02) | 0.95 (0.90, 1.00) | 0.97 (0.92, 1.02) | 0.09 |
HPFS | ||||||
No. of cases | 1107 | 1222 | 1130 | 1085 | 1092 | — |
Person-years | 42,932 | 43,795 | 43,113 | 42,509 | 40,414 | — |
Relative risk (95% CI) | 1.0 (ref) | 1.12 (1.03, 1.22) | 1.05 (0.96, 1.15) | 1.05 (0.96, 1.15) | 1.09 (0.98, 1.20) | 0.44 |
Pooled relative risk (95% CI) | 1.0 (ref) | 1.02 (0.96, 1.09) | 0.98 (0.92, 1.04) | 0.98 (0.93, 1.03) | 0.99 (0.93, 1.06) | 0.28 |
Flavonones | ||||||
NHS II | ||||||
No. of cases | 2334 | 2347 | 2285 | 2267 | 2169 | — |
Person-years | 156,829 | 166,072 | 166,546 | 167,819 | 165,573 | — |
Relative risk (95% CI) | 1.0 (ref) | 0.97 (0.92, 1.03) | 0.96 (0.91, 1.02) | 0.98 (0.92, 1.04) | 0.98 (0.92, 1.05) | 0.92 |
NHS I | ||||||
No. of cases | 3497 | 3892 | 3679 | 3424 | 3124 | — |
Person-years | 103,246 | 108,915 | 104,344 | 101,934 | 92,642 | — |
Relative risk (95% CI) | 1.0 (ref) | 1.04 (0.99, 1.09) | 1.01 (0.97, 1.06) | 0.97 (0.92, 1.02) | 0.99 (0.94, 1.05) | 0.14 |
HPFS | ||||||
No. of cases | 1161 | 1215 | 1168 | 1084 | 1008 | — |
Person-years | 43,591 | 45,209 | 43,482 | 41,617 | 38,864 | — |
Relative risk (95% CI) | 1.0 (ref) | 1.05 (0.96, 1.14) | 1.04 (0.92, 1.13) | 1.05 (0.95, 1.15) | 1.04 (0.94, 1.14) | 0.63 |
Pooled relative risk (95% CI) | 1.0 (ref) | 1.02 (0.97, 1.07) | 1.00 (0.96, 1.04) | 0.99 (0.95, 1.02) | 0.99 (0.96, 1.03) | 0.39 |
Anthocyanins | ||||||
NHS II | ||||||
No. of cases | 2379 | 2344 | 2301 | 2276 | 2102 | — |
Person-years | 150,085 | 163,823 | 168,435 | 170,786 | 169,711 | — |
Relative risk (95% CI) | 1.0 (ref) | 0.94 (0.88, 0.99) | 0.93 (0.87, 0.98) | 0.91 (0.86, 0.97) | 0.87 (0.81, 0.92)* | <0.0001 |
NHS I | ||||||
No. of cases | 3531 | 3569 | 3640 | 3616 | 3260 | — |
Person-years | 100,201 | 102,378 | 103,767 | 104,063 | 100,673 | — |
Relative risk (95% CI) | 1.0 (ref) | 0.96 (0.91, 1.00) | 0.97 (0.92, 1.02) | 0.98 (0.93, 1.03) | 0.93 (0.88, 0.98)* | 0.02 |
HPFS | ||||||
No. of cases | 1137 | 1168 | 1140 | 1112 | 1079 | — |
Person-years | 41,162 | 42,906 | 43,290 | 43,756 | 41,648 | — |
Relative risk (95% CI) | 1.0 (ref) | 0.99 (0.91, 1.08) | 0.97 (0.89, 1.06) | 0.98 (0.89, 1.07) | 0.99 (0.90, 1.09) | 0.82 |
Pooled relative risk (95% CI) | 1.0 (ref) | 0.96 (0.93, 0.99) | 0.96 (0.92, 0.99) | 0.95 (0.91, 1.01) | 0.92 (0.86, 0.98)* | 0.03 |
Flavan-3-ols | ||||||
NHS II | ||||||
No. of cases | 2332 | 2134 | 2170 | 2311 | 2455 | — |
Person-years | 159,269 | 166,255 | 170,197 | 165,959 | 161,159 | — |
Relative risk (95% CI) | 1.0 (ref) | 0.97 (0.91, 1.03) | 0.96 (0.90, 1.02) | 1.00 (0.94, 1.06) | 1.03 (0.97, 1.09) | 0.08 |
NHS I | ||||||
No. of cases | 3406 | 3533 | 3562 | 3597 | 3518 | — |
Person-years | 98,181 | 103,210 | 103,130 | 102,945 | 103,615 | — |
Relative risk (95% CI) | 1.0 (ref) | 1.00 (0.95, 1.05) | 1.01 (0.96, 1.06) | 1.01 (0.96, 1.06) | 0.98 (0.93, 1.03) | 0.31 |
HPFS | ||||||
No. of cases | 1031 | 1104 | 1220 | 1141 | 1140 | — |
Person-years | 40,501 | 43,027 | 44,372 | 43,659 | 41,204 | — |
Relative risk (95% CI) | 1.0 (ref) | 1.06 (0.97, 1.16) | 1.14 (1.04, 1.24) | 1.07 (0.98, 1.18) | 1.12 (1.02, 1.22) | 0.10 |
Pooled relative risk (95% CI) | 1.0 (ref) | 1.00 (0.96, 1.04) | 1.03 (0.95, 1.12) | 1.01 (0.98, 1.05) | 1.03 (0.97, 1.11) | 0.40 |
Polymers | ||||||
NHS II | ||||||
No. of cases | 2331 | 2155 | 2234 | 2253 | 2429 | — |
Person-years | 159,191 | 166,861 | 168,412 | 166,666 | 161,709 | — |
Relative risk (95% CI) | 1.0 (ref) | 0.93 (0.88, 0.99) | 0.96 (0.91, 1.02) | 0.96 (0.91, 1.02) | 1.00 (0.94, 1.06) | 0.34 |
NHS I | ||||||
No. of cases | 3456 | 3576 | 3551 | 3469 | 3564 | — |
Person-years | 97,859 | 103,301 | 103,129 | 102,945 | 103,848 | — |
Relative risk (95% CI) | 1.0 (ref) | 0.98 (0.94, 1.03) | 0.98 (0.93, 1.03) | 0.96 (0.91, 1.01) | 0.97 (0.93, 1.02) | 0.56 |
HPFS | ||||||
No. of cases | 1125 | 1127 | 1153 | 1091 | 1140 | — |
Person-years | 40,257 | 44,229 | 44,312 | 43,379 | 40,586 | — |
Relative risk (95% CI) | 1.0 (ref) | 0.98 (0.90,1.07) | 1.04 (0.95,1.13) | 0.99 (0.90,1.08) | 1.08 (0.99,1.18) | 0.04 |
Pooled relative risk (95% CI) | 1.0 (ref) | 0.96 (0.93, 1.00) | 0.98 (0.95, 1.02) | 0.96 (0.93, 1.00) | 1.01 (0.95, 1.06) | 0.36 |
Total flavonoids | ||||||
NHS II | ||||||
No. of cases | 2330 | 2192 | 2253 | 2216 | 2411 | — |
Person-years | 159,191 | 166,861 | 168,412 | 166,666 | 161,709 | — |
Relative risk (95% CI) | 1.0 (ref) | 0.95 (0.90, 1.01) | 0.99 (0.93, 1.05) | 0.96 (0.90, 1.02) | 1.01 (0.95, 1.07) | 0.41 |
NHS I | ||||||
No. of cases | 3615 | 3574 | 3468 | 3433 | 3526 | — |
Person-years | 102,510 | 103,094 | 101,273 | 101,300 | 102,905 | — |
Relative risk (95% CI) | 1.0 (ref) | 0.96 (0.91, 1.00) | 0.94 (0.89, 0.98) | 0.92 (0.88, 0.97) | 0.94 (0.90, 0.99)* | 0.40 |
HPFS | ||||||
No. of cases | 1166 | 1124 | 1124 | 1094 | 1128 | — |
Person-years | 41,618 | 44,231 | 44,329 | 42,267 | 40,318 | — |
Relative risk (95% CI) | 1.0 (ref) | 0.96 (0.88, 1.05) | 0.99 (0.91, 1.08) | 0.99 (0.91, 1.09) | 1.06 (0.97, 1.16) | 0.04 |
Pooled relative risk (95% CI) | 1.0 (ref) | 0.96 (0.93, 0.99) | 0.97 (0.93, 1.00) | 0.95 (0.91, 0.98) | 1.00 (0.93, 1.07) | 0.46 |
ref, reference. Multivariate model included age and smoking, BMI, physical activity, alcohol consumption, family history of hypertension, aspirin use, multivitamin use, and intakes of sodium, magnesium, potassium, fiber, whole grain, folate, and caffeine. *Quintile 5 compared with quintile 1, P < 0.001.